Cymabay Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
60%
€6.95
Target price
31.03.26
€20.00
Performance (%)
101.44%
End price
01.10.23
€14.00
Summary
This prediction ended on 01.10.23 with a price of €14.00. With a performance of 101.44% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cymabay Therapeutics Inc | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% |
According to BiotechBee what are the pros and cons of Cymabay Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Buy mit Kursziel 11,0
Kursziel geändert auf 20,0
In the thread Trading Cymabay Therapeutics Inc
Buy beendet
Stopped prediction by BiotechBee for Cymabay Therapeutics Inc
Cymabay Therapeutics Inc
Start price
Target price
Perf. (%)
€15.70
12.11.23
12.11.23
€20.00
31.03.26
31.03.26
89.81%
17.02.24
17.02.24
Could be very worthwhile Investment >20% year